Oral acyclovir - 400 mg BID (HSV); 800mg BID (HZV) ororal valacyclovir - 500 mg BIDTenofovir or entecavir (instead of lamivudine) in patients at intermediate or high risk of hepatitis B reactivation. Here, PPIB is linked to Hepatitis.